UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations

UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations

Source: 
Fierce Biotech
snippet: 

UniQure is looking to jump-start a phase 1/2 trial for a Huntington's disease gene therapy after a safety monitoring board gave the go-ahead for dosing to resume.